Clinical Trials Directory

Trials / Completed

CompletedNCT01952678

Compare Rates of Agreement Between Clinical Diagnosis and Visual Assessment of DaTscan™ Images in Non-Caucasian and Caucasian Subjects With Parkinson's Disease (PD) or Essential Tremor (ET)

A Retrospective Clinical Study to Compare the Rates of Agreement Between Clinical Diagnosis and Visual Assessment of DaTscan™ Images in Non-Caucasian and Caucasian Subjects With Parkinson's Disease (PD) or Essential Tremor (ET)

Status
Completed
Phase
Study type
Observational
Enrollment
204 (actual)
Sponsor
GE Healthcare · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to determine if the diagnostic performance of DaTscan™ single photon emission computed tomography (SPECT) imaging is different in non-Caucasian subjects compared with Caucasian subjects with movement disorders.

Conditions

Interventions

TypeNameDescription
OTHERDaTscan™ - Non-Caucasian ParticipantsParticipants who previously administered DaTscan™ and had undergone SPECT imaging of the brain per local practice at each institution.
OTHERDaTscan™ - Caucasian ParticipantsParticipants who previously administered DaTscan™ and had undergone SPECT imaging of the brain per local practice at each institution.

Timeline

Start date
2013-07-30
Primary completion
2016-05-01
Completion
2016-05-01
First posted
2013-09-30
Last updated
2018-08-02
Results posted
2018-08-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01952678. Inclusion in this directory is not an endorsement.

Compare Rates of Agreement Between Clinical Diagnosis and Visual Assessment of DaTscan™ Images in Non-Caucasian and Cauc (NCT01952678) · Clinical Trials Directory